News
DRIO
--
0.00%
--
DarioHealth partners with Mediorbis on virtual care offering for diabetes
DarioHealth (DRIO) announces the launch of a new virtual care initiative with MediOrbis, a telehealth provider specializing in chronic conditions.As part of the launch, the new virtual care program will
Seekingalpha · 22h ago
DarioHealth Teams Up with MediOrbis on Virtual Care Offering for Diabetes
MT Newswires · 23h ago
BRIEF-Dariohealth Says Selling Stockholders May Offer From Time To Time Up To 3.3 Million Shares Of Stock
reuters.com · 04/01 23:07
Stifel initiates DarioHeath with a buy and $30 price target
Stifel has initiated shares of DarioHealth (DRIO) with a buy rating and a $30 price target.Analyst David Grossman writes that the company is an "emerging player" in the "larger, under-penetrated
Seekingalpha · 03/23 15:40
The Necessity of Corporate Wellness Could Create $100 Billion Opportunity
Baystreet.ca · 03/23 13:45
DJ DarioHealth Initiated at Buy by Stifel
Dow Jones · 03/23 10:42
DJ DarioHealth Price Target Announced at $30.00/Share by Stifel
Dow Jones · 03/23 10:42
ZVO, SNCA, TKC and MRKR among midday movers
Gainers: Support.com (SPRT) +246%.Jiayin Group (JFIN) +40%.Summer Infant (SUMR) +36%.Hall of Fame Resort & Entertainment (HOFV) +32%.Recon Technology (RCON) +31%.Seneca Biopharma (SNCA) +24%.Dyadic International (DYAI) +22%.DarioHealth (DRIO) +20%.Marker T...
Seekingalpha · 03/22 16:41
Dyadic International, Seneca Biopharma leads healthcare gainers; Odonate Therapeutics, Foghorn Therapeutics among major losers
Gainers: Seneca Biopharma (SNCA) +25%, DarioHealth (DRIO) +25%, Dyadic International DYAI +24%, Marker Therapeutics (MRKR) +19%, Immunocore Holdings (IMCR) +11%.Losers: Odonate Therapeutics ODT -76%, Foghorn Therapeutics (FHTX) -13, Forian (FORA) -12%%, At...
Seekingalpha · 03/22 15:02
DRIO: Fourth Quarter and Fiscal Year 2020 Financial and Operational Results
By John Vandermosten, CFA NASDAQ:DRIO READ THE FULL DRIO RESEARCH REPORT On March 9, 2021, DarioHealth Corp. (NASDAQ:DRIO) announced its fourth quarter and FY:20 operational and financial results and filed its form 10-K. 2020 marked a transformative year f...
Zacks Small Cap Research · 03/17 10:55
BioMedNewsBreaks - DarioHealth Corp. (NASDAQ: DRIO) Reports Q4, FY 2020 Numbers, Business Highlights
Mar 09, 2021 (Investor Brand Network via COMTEX) -- DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, has released its...
Investor Brand Network · 03/09 16:57
The Daily Biotech Pulse: Regulatory Setback For Acadia, Lilly Forges Diabetes Antibody Treatment Collaboration, Aytu's Positive COVID-19 Data
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 8)
Benzinga · 03/09 13:08
BRIEF-DarioHealth Reports 18.1% Increase In Quarterly Non-GAAP Billings
reuters.com · 03/09 11:41
DarioHealth misses on revenue
DarioHealth (DRIO): Q4 net loss of $9.0M.Revenue of $2.08M (+15.6% Y/Y) misses by $0.03M.Press Release
Seekingalpha · 03/09 11:36
DarioHealth Q4 Sales $2.08M Inline
DarioHealth (NASDAQ:DRIO) reported quarterly sales of $2.08 million which met the analyst consensus estimate. This is a 15.68 percent increase over sales of $1.80 million the same period last year.
Benzinga · 03/09 11:33
DarioHealth Reports Fourth Quarter and Full Year 2020 Results and Operational Highlights
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the fourth quarter and full year 2020 and provided a corporate and commercial update.
PR Newswire · 03/09 11:30
10-K: DARIOHEALTH CORP.
(EDGAR Online via COMTEX) -- Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operation Readers are advised to review the...
Edgar Online - (EDG = 10Q, 10K) · 03/09 11:02
DarioHealth Corp. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / March 9, 2021 / DarioHealth Corp. (NASDAQ:DRIO) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 9, 2021 at 8:30 AM Eastern Time.
ACCESSWIRE · 03/09 10:30
A Preview Of DarioHealth's Earnings
Benzinga · 03/08 15:08
The Week Ahead In Biotech (March 7-13): Conference Presentations And More Earnings
Biotech stocks continued to move southward in the week ended March 5, as the broader market extended its sell-off. Though light on news, the week did witness earnings releases from smaller biopharma companies, coronavirus vaccine program updates, mixed FDA...
Benzinga · 03/06 15:57
Webull provides a variety of real-time DRIO stock news. You can receive the latest news about DarioHealth through multiple platforms. This information may help you make smarter investment decisions.
About DRIO
DarioHealth Corp. (DarioHealth) is a Digital Therapeutics (DTx) company. DarioHealth operates at the intersection of life sciences, behavioral science, and software technology to deliver integrated and engaging digital therapeutics interventions. The DTx products are centered around its users and include the Dario Blood Glucose Monitoring System and the Dario Smart Diabetes Management Solution, which are provided to its users in the form of a smartphone application that enables the delivery of content and periodical evidence-based reports; the DarioEngage platform, which provides support and two-way real-time connectivity between its users and their caregivers, and Dario Intelligence, which utilizes user data and is an analytics tool that can assist healthcare providers in the treatments and predictability of diseases. The Company’s services are available direct to consumers via online marketplaces including Amazon, Walmart, Best Buy and the Google and Apple app stores.